NLGIA
BMRN icon

Nippon Life Global Investors Americas’s BioMarin Pharmaceuticals BMRN Stock Holding History

Nippon Life Global Investors Americas’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,070
Closed -$3.09M – 108
2023
Q4 		$3.09M Hold
32,070
– – 0.17% 77
2023
Q3 		$2.84M Sell
32,070
-215,210
-87% -$19.1M 0.17% 78
2023
Q2 		$21.4M Sell
247,280
-25,180
-9% -$2.37M 1.45% 19
2023
Q1 		$26.5M Sell
272,460
-13,950
-5% -$1.45M 1.7% 16
2022
Q4 		$29.6M Buy
286,410
+10,200
+4% +$958K 1.96% 12
2022
Q3 		$23.4M Buy
276,210
+57,430
+26% +$5.11M 1.65% 16
2022
Q2 		$18.1M Hold
218,780
– – 1.17% 24
2022
Q1 		$16.9M Sell
218,780
-10,620
-5% -$889K 0.9% 32
2021
Q4 		$20.3M Sell
229,400
-1,360
-0.6% -$112K 0.96% 27
2021
Q3 		$17.8M Buy
230,760
+17,580
+8% +$1.39M 0.93% 27
2021
Q2 		$17.8M Sell
213,180
-8,680
-4% -$688K 0.89% 30
2021
Q1 		$16.8M Buy
221,860
+7,640
+4% +$624K 0.92% 31
2020
Q4 		$18.8M Hold
214,220
– – 1.12% 25
2020
Q3 		$16.3M Buy
214,220
+7,210
+3% +$729K 1.07% 22
2020
Q2 		$25.5M Sell
207,010
-36,370
-15% -$3.61M 1.82% 11
2020
Q1 		$20.6M Buy
+243,380
New +$21M 1.8% 15

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nippon Life Global Investors Americas's BMRN Position: Q1 2024 in Review

Nippon Life Global Investors Americas sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2024, closing a stake of 32,070 shares — an estimated $3.09M sold.

Nippon Life Global Investors Americas first reported a position in BMRN in Q1 2020 and held it in 16 quarters. The position peaked at $29.6M in Q4 2022. 561 funds tracked by Wall St. Rank hold BMRN as of Q1 2024.

  • Nippon Life Global Investors Americas reported no remaining BioMarin Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 32,070 BioMarin Pharmaceuticals shares in Q1 2024, an estimated $3.09M.
  • Nippon Life Global Investors Americas first reported a position in BioMarin Pharmaceuticals in Q1 2020 and held it in 16 quarters.
  • Nippon Life Global Investors Americas's BioMarin Pharmaceuticals position peaked at $29.6M in Q4 2022.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2024.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2024, filed 15 May 2024.